Quantcast

Latest MedAvante Inc. Stories

2014-05-07 12:30:15

Standardizing Site Networks for CNS Clinical Trials Boosts Signal Detection HAMILTON, N.J., May 7, 2014 /PRNewswire/ -- MedAvante, Inc., the world's leading provider of centralized assessments and quality control in clinical trials of treatments for central nervous system (CNS) disorders, announced the Virgil Investigative Study Platform for use by drug developers and their global cohort of trial sites. For the first time, the Virgil platform puts tools built with MedAvante science...

2011-06-08 09:01:00

HAMILTON, N.J., June 8, 2011 /PRNewswire/ -- MedAvante, Inc., the leader in centralized expert evaluation of treatments for central nervous system disorders, announced it has added significant operations in Eastern and Western Europe, supported by a hub office in Munich, Germany, to complement its Centralized Ratings services offered in the United States and Russia. MedAvante Centralized Ratings will expand to well over a dozen countries before the end of the year. "MedAvante has reached...

2011-01-10 09:19:00

HAMILTON, N.J., Jan. 10, 2011 /PRNewswire/ -- MedAvante, Inc., the leader in centralized expert evaluation of treatments for central nervous system (CNS) disorders, announced the appointment of Christopher Randolph, PhD, ABPP-CN, to the new position of Vice President, Neurocognition. Dr. Randolph will lead a growing team of clinical and training experts and experienced, calibrated clinicians focusing on Alzheimer's disease (AD), mild cognitive impairment (MCI) and other neurocognitive...

2010-12-07 10:35:00

HAMILTON, N.J., Dec. 7, 2010 /PRNewswire/ -- MedAvante, Inc., the leader in centralized expert evaluation of treatments for central nervous system disorders, announced that Cipher Pharmaceuticals is using MedAvante Centralized Ratings in their pivotal Phase 3 dermatology study. Cipher recently announced the completion of the patient enrollment phase of their clinical study, in which every patient is interviewed by a qualified MedAvante mental health expert at every visit of the study....

2010-10-26 09:00:00

HAMILTON, N.J. and ROCKVILLE, Md., Oct. 26 /PRNewswire/ -- MedAvante, Inc., the leader in centralized expert evaluation of central nervous system (CNS) disorders, and Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN) a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, announced that Rexahn will use MedAvante 's Remote Centralized Ratings(TM) in their randomized, double-blind, placebo-controlled Phase 2b clinical study...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related